Important Safety Information — Hydroquinone (Topical)

Indications

Hydroquinone is a topical depigmenting agent indicated for the gradual lightening of hyperpigmented skin conditions such as melasma, post-inflammatory hyperpigmentation, age spots (solar lentigines), and freckles. It works by inhibiting the enzymatic oxidation of tyrosine to DOPA (3,4-dihydroxyphenylalanine), thereby reducing melanin production.

Contraindications

• Known hypersensitivity or prior allergic reaction to hydroquinone or any component of the formulation
• Sulfite allergy: Some formulations contain sodium metabisulfite, which may cause serious allergic reactions (hives, itching, wheezing, anaphylaxis, or severe asthma attacks) in susceptible individuals

Warnings and Precautions

• Skin sensitivity testing: A small amount should be applied to an unbroken patch of skin and checked within 24 hours before beginning treatment. If itching, vesicle formation, or excessive inflammatory response occurs, do not use the product.
• Sun protection (essential): Sunscreen use is a critical component of hydroquinone therapy. Even minimal sun exposure sustains melanocytic activity and can reverse the depigmenting effect. Apply a broad-spectrum sunscreen (SPF 15 or greater) daily and use protective clothing. Avoid prolonged sun exposure.
• Ochronosis: On rare occasions, prolonged use of hydroquinone (especially at higher concentrations or in dark-skinned individuals) may cause a gradual blue-black darkening of the skin (exogenous ochronosis). Discontinue use immediately if this occurs and consult a physician.
• Eye contact: Avoid contact with the eyes. If contact occurs, rinse thoroughly with water.
• Limited duration of use: Hydroquinone is generally recommended for intermittent use (e.g., 3-6 month cycles with breaks) rather than continuous long-term application, to reduce the risk of ochronosis.
• Avoid on broken skin: Do not apply to open wounds, cuts, or irritated skin.

Common Side Effects

• Mild burning or stinging at the application site
• Skin redness (erythema)
• Dryness
• Mild itching
• Skin peeling

Serious Side Effects

Discontinue use and seek medical attention if you experience any of the following:

• Blue-black darkening of the treated skin (ochronosis) -- discontinue immediately
• Severe skin irritation, blistering, or oozing
• Signs of allergic reaction: hives, difficulty breathing, severe itching, swelling of the face, lips, tongue, or throat
• Signs of a severe asthma attack (in sulfite-sensitive patients)
• Persistent or worsening skin discoloration

Drug Interactions

• Other topical depigmenting agents: Use with caution when combining with other skin-lightening products, as the risk of irritation increases.
• Benzoyl peroxide: May cause temporary staining of the skin when used with hydroquinone. Avoid simultaneous application; if both are used, apply at different times of day.
• Hydrogen peroxide-based products: May interact and cause skin staining or irritation.
• Topical retinoids (e.g., tretinoin): Combination use is common in dermatology under provider supervision, but can increase irritation. Follow your provider's instructions for timing and application.
• Topical corticosteroids: Often used in combination under medical supervision. Do not self-prescribe combinations.

Use in Specific Populations

• Pregnancy: The safety of topical hydroquinone use during pregnancy has not been established. Avoid use during pregnancy unless directed by your healthcare provider.
• Lactation: It is not known whether topical hydroquinone is absorbed systemically or excreted in human breast milk. Use with caution during breastfeeding.
• Pediatric use: Safety and effectiveness in children 12 years and under have not been established.
• Sensitive skin: Patients with sensitive skin or a history of allergic contact dermatitis should perform a patch test before use.